Authors: Jutiyar Ibrahim1 & Hêro Farhad Salah2
1Department of Biology, College of Education, Salahaddin University-Erbil, Kurdistan Region of Iraq
2Department of Biology, College of Education, Salahaddin University-Erbil, Kurdistan Region of Iraq
Abstract: Recently, it has been proved that some of Enterobacteriaceae like Klebsiella pneumoniae, which carry polyketide synthase (PKS) islands, damage human dsDNA by encoding Colibactin genotoxin; and finally, they induce some apoptosis in damaged mucosal cells. This study aimed to isolate the clbN and clbB genes, which are the markers of the PKS genomic island, from PKS cluster in these bacteria.
In this study, 100 biopsies were obtained, 50 from them from colorectal cancer patients and another 50 from normal patients as control from PAR International Hospital. Then, all samples were cultured on MacConkey agar medium and blood agar medium for bacterial isolation then, Klebsiella pneumoniae was identified by some biochemical testes (indole test, Cimon citrate test, urease test) and Vitek technique. Finally, The DNA of bacteria was extracted and then were amplified by PCR with specific clbB and clbN gene primers. We obtained (8) isolates out of 50 biopsies from patients with colorectal cancer; and 2 isolates Klebsiella pneumoniae out of 50 non-colorectal cancer patients as control. Further, all (8) Klebsiella pneumoniae that we obtained from colorectal cancer patients had both clbB and clbN genes. Whereas 2 Klebsiella pneumoniae that obtained from non-colorectal patients had just clbB and they did not have clbN. In this investigation conducted in Erbil province, Klebsiella pneumoniae with pks+ island was considerably greater in CRC patients compared to non-cancer individuals.
Keywords: Colorectal Cancer, Klebsiella pneumoniae, pks+ island, clbB, clbN, PCR
Published: February 10, 2023
ARTHUR, J. C., PEREZ-CHANONA, E., MÜHLBAUER, M., TOMKOVICH, S., URONIS, J. M., FAN, T.-J., CAMPBELL, B. J., ABUJAMEL, T., DOGAN, B. & ROGERS, A. B. (2012).
Intestinal inflammation targets cancer-inducing activity of the microbiota. science, 338, 120-123.
BROTHERTON, C. A. & BALSKUS, E. P. (2013). A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity. Journal of the American Chemical Society, 135, 3359-3362.
BUC, E., DUBOIS, D., SAUVANET, P., RAISCH, J., DELMAS, J., DARFEUILLE-MICHAUD,
A., PEZET, D. & BONNET, R. (2013). High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PloS one, 8, e56964.
CANDAN, E. D. & AKSÖZ, N. (2015). Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochimica Polonica, 62.
CHEN, Y.-T., LAI, Y.-C., TAN, M.-C., HSIEH, L.-Y., WANG, J.-T., SHIAU, Y.-R., WANG, H.-
Y., LIN, A.-C., LAI, J.-F. & HUANG, I.-W. (2017). Prevalence and characteristics of pks genotoxin gene cluster-positive clinical Klebsiella pneumoniae isolates in Taiwan.
Scientific reports, 7, 1-10.
HAMA, H. A., & KARIM, A. Y. (2019). Evaluation of p53 expression among Colorectal Cancer
patients. Zanco Journal of Pure and Applied Sciences, 31(6), 130-134.
GIOVANNUCCI, E. & WILLETT, W. C. (1994). Dietary factors and risk of colon cancer. Annals of medicine, 26, 443-452.
KUROKAWA, K., ITOH, T., KUWAHARA, T., OSHIMA, K., TOH, H., TOYODA, A., TAKAMI, H., MORITA, H., SHARMA, V. K. & SRIVASTAVA, T. P. (2007). Comparative
metagenomics revealed commonly enriched gene sets in human gut microbiomes. Dna Research, 14, 169-181.
LOZUPONE, C. A., STOMBAUGH, J. I., GORDON, J. I., JANSSON, J. K. & KNIGHT, R. (2012).
Diversity, stability and resilience of the human gut microbiota. Nature, 489, 220-230.
MOHANDAS, K. (2011). Colorectal cancer in India: controversies, enigmas and primary prevention. Springer.
NOUGAYRÈDE, J.-P., HOMBURG, S., TAIEB, F., BOURY, M., BRZUSZKIEWICZ, E., GOTTSCHALK, G., BUCHRIESER, C., HACKER, J. R., DOBRINDT, U. & OSWALD,
E. (2006). Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science,
RISTUCCIA, P. A. & CUNHA, B. A. (1984). Klebsiella. Infection Control & Hospital Epidemiology, 5, 343-347.
SHIMPOH, T., HIRATA, Y., IHARA, S., SUZUKI, N., KINOSHITA, H., HAYAKAWA, Y., OTA,
Y., NARITA, A., YOSHIDA, S. & YAMADA, A. (2017). Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer. Gut pathogens, 9, 1-8.
TOMKOVICH, S. & JOBIN, C. (2018). Microbial networking in cancer: when two toxins collide.
Nature Publishing Group.
WERNKE, K. M., XUE, M., TIRLA, A., KIM, C. S., CRAWFORD, J. M. & HERZON, S. B.
(2020). Structure and bioactivity of colibactin. Bioorganic & medicinal chemistry letters,